REVANCE THERAPEUTICS INC

CUSIP: 761330AB5 Class: NOTE 1.750% 2/1

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 40,000,000 Value ($000) $38,300 Avg Close — Range —
Q3 2024
Shares 40,000,000 Value ($000) $34,344 Avg Close — Range —
Q2 2024
Shares 40,000,000 Value ($000) $26,331 Avg Close — Range —
Q1 2024
Shares 40,000,000 Value ($000) $29,496 Avg Close — Range —
Q4 2023
Shares 31,500,000 Value ($000) $24,028 Avg Close — Range —
Q3 2023
Shares 20,000,000 Value ($000) $16,177 Avg Close — Range —
Q3 2022
Shares 20,000,000 Value ($000) $21,629,000 Avg Close — Range —
Q2 2022
Shares 20,000,000 Value ($000) $16,349,000 Avg Close — Range —